159 related articles for article (PubMed ID: 32372148)
21. Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host disease.
Gavriilaki E; Sakellari I; Karafoulidou I; Pasteli N; Batsis I; Mallouri D; Lazaridou A; Iskas M; Vardi A; Papalexandri A; Tsompanakou A; Papaemmanouil S; Ilias A; Anagnostopoulos A
Int J Hematol; 2019 Nov; 110(5):529-532. PubMed ID: 31586304
[TBL] [Abstract][Full Text] [Related]
22. Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Mii A; Shimizu A; Kaneko T; Fujita E; Fukui M; Fujino T; Utsumi K; Yamaguchi H; Tajika K; Tsuchiya S; Iino Y; Katayama Y; Fukuda Y
Pathol Int; 2011 Sep; 61(9):518-27. PubMed ID: 21884301
[TBL] [Abstract][Full Text] [Related]
23. Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning.
Willems E; Baron F; Seidel L; Frère P; Fillet G; Beguin Y
Bone Marrow Transplant; 2010 Apr; 45(4):689-93. PubMed ID: 19718063
[TBL] [Abstract][Full Text] [Related]
24. Acquired Complement Regulatory Gene Mutations and Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy.
Ardissino G; Salardi S; Berra S; Colussi G; Cugno M; Zecca M; Giglio F; Peccatori J; Diral E; Tel F; Clivio A; Tedeschi S
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1580-1582. PubMed ID: 28522344
[TBL] [Abstract][Full Text] [Related]
25. Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy.
Peffault de Latour R; Xhaard A; Fremeaux-Bacchi V; Coppo P; Fischer AM; Helley D; Socié G
Br J Haematol; 2013 Apr; 161(2):279-80. PubMed ID: 23294015
[No Abstract] [Full Text] [Related]
26. Plasmapheresis-refractory thrombotic microangiopathy in a hematopoietic stem cell transplant recipient.
Vasko R; Groenewold F; Korsten P; Müller GA; Koziolek M
Ther Apher Dial; 2011 Oct; 15(5):507-9. PubMed ID: 21974708
[No Abstract] [Full Text] [Related]
27. Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxis.
Shayani S; Palmer J; Stiller T; Liu X; Thomas SH; Khuu T; Parker PM; Khaled SK; Forman SJ; Nakamura R
Biol Blood Marrow Transplant; 2013 Feb; 19(2):298-304. PubMed ID: 23078784
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of endothelial injury and transplant-associated thrombotic microangiopathy in tandem autologous hematopoietic stem cell transplant for neuroblastoma.
Sabulski A; Abdullah S; Luebbering N; Aunins B; Castillo C; Lake K; Duell A; Strecker L; Langenberg L; Broomhead W; DiMeo S; Odegard EA; Blackard JT; Ziady AG; Seif AE; Dandoy CE; Laskin BL; Jodele S; Davies SM
Haematologica; 2023 Dec; 108(12):3449-3453. PubMed ID: 37317894
[No Abstract] [Full Text] [Related]
29. Use of eculizumab in autologous hematopoietic stem cell transplantation-associated thrombotic microangiopathy in two adults.
Alhomoud M; Williams A; Magro C; Van Besien K; Vesole DH; Laurence J
Leuk Lymphoma; 2022 Feb; 63(2):473-477. PubMed ID: 34668824
[No Abstract] [Full Text] [Related]
30. Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.
Gavriilaki E; Sakellari I; Batsis I; Mallouri D; Bousiou Z; Vardi A; Yannaki E; Constantinou V; Tsompanakou A; Vadikoliou C; Kaloyannidis P; Bamihas G; Anagnostopoulos A
Clin Transplant; 2018 Sep; 32(9):e13371. PubMed ID: 30080283
[TBL] [Abstract][Full Text] [Related]
31. Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC.
de Fontbrune FS; Galambrun C; Sirvent A; Huynh A; Faguer S; Nguyen S; Bay JO; Neven B; Moussi J; Simon L; Xhaard A; Resche-Riggon M; O'Meara A; Fremeaux-Bacchi V; Veyradier A; Socié G; Coppo P; de Latour RP
Transplantation; 2015 Sep; 99(9):1953-9. PubMed ID: 25651309
[TBL] [Abstract][Full Text] [Related]
32. Chronic kidney disease, thrombotic microangiopathy, and hypertension following T cell-depleted hematopoietic stem cell transplantation.
Glezerman IG; Jhaveri KD; Watson TH; Edwards AM; Papadopoulos EB; Young JW; Flombaum CD; Jakubowski AA
Biol Blood Marrow Transplant; 2010 Jul; 16(7):976-84. PubMed ID: 20153836
[TBL] [Abstract][Full Text] [Related]
33. Transplant-associated thrombotic microangiopathy: an unresolved complication of unrelated allogeneic transplant for hematologic diseases.
Sakellari I; Gavriilaki E; Boussiou Z; Batsis I; Mallouri D; Constantinou V; Kaloyannidis K; Yannaki E; Bamihas G; Anagnostopoulos A
Hematol Oncol; 2017 Dec; 35(4):932-934. PubMed ID: 27641429
[No Abstract] [Full Text] [Related]
34. TMA: beware of complements.
Ricklin D; Cines DB
Blood; 2013 Sep; 122(12):1997-9. PubMed ID: 24052540
[TBL] [Abstract][Full Text] [Related]
35. Distribution of Transplantation-Associated Thrombotic Microangiopathy (TA-TMA) and Comparison between Renal TA-TMA and Intestinal TA-TMA: Autopsy Study.
Yamada R; Nemoto T; Ohashi K; Tonooka A; Horiguchi SI; Motoi T; Hishima T
Biol Blood Marrow Transplant; 2020 Jan; 26(1):178-188. PubMed ID: 31491486
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus.
Labrador J; López-Corral L; López-Godino O; Vázquez L; Cabrero-Calvo M; Pérez-López R; Díez-Campelo M; Sánchez-Guijo F; Pérez-López E; Guerrero C; Alberca I; Del Cañizo MC; Pérez-Simón JA; González-Porras JR; Caballero D
Bone Marrow Transplant; 2014 May; 49(5):684-90. PubMed ID: 24566710
[TBL] [Abstract][Full Text] [Related]
37. Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation.
Arai Y; Yamashita K; Mizugishi K; Watanabe T; Sakamoto S; Kitano T; Kondo T; Kawabata H; Kadowaki N; Takaori-Kondo A
Biol Blood Marrow Transplant; 2013 Dec; 19(12):1683-9. PubMed ID: 24055655
[TBL] [Abstract][Full Text] [Related]
38. Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation.
Kojouri K; George JN
Curr Opin Oncol; 2007 Mar; 19(2):148-54. PubMed ID: 17272988
[TBL] [Abstract][Full Text] [Related]
39. Clinical usefulness of diagnostic criteria for transplant-associated thrombotic microangiopathy.
Sagou K; Fukushima N; Ukai S; Goto M; Ozeki K; Kohno A
Int J Hematol; 2020 Nov; 112(5):697-706. PubMed ID: 32748214
[TBL] [Abstract][Full Text] [Related]
40. Successful Treatment of Veno-occlusive Disease, Transplantation-Associated Thrombotic Microangiopathy, and Acute Graft-vs-Host Disease in a Patient with Relapsed Epstein-Barr Hemophagocytic Lymphohistiocytosis After Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report.
Zhang C; Tan X; Yao H; Liu Y; Gao L; Gao L; Kong PY; Zhang X
Transplant Proc; 2019 Nov; 51(9):3159-3162. PubMed ID: 31711585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
